title: Pharmaceutical innovation in the United States. Factors affecting future performance.
abstract: Fueled by high returns on its investments, the pharmaceutical industry in the United States has flourished for the past 50 years. The regulatory strategy of demanding stringent testing then allowing market-based pricing has allowed private companies to fund ambitious research and development activities with the assurance that these investments will be recovered. However, aggressive managed-care cost-containment strategies threaten the companies' ability to recoup research and development expenses and may affect their willingness to invest in future innovative research.
authors.affiliation: Michaels & Wishner, PC, Washington, DC 20036.
authors.forename: M R
authors.initials: MR
authors.lastname: Pollard
mesh_terms: D004059:Diffusion of Innovation; D004345:Drug Industry / Q000331:legislation & jurisprudence / Q000639:trends*; D005544:Forecasting; D006291:Health Policy; D009936:Organizational Innovation; D014481:United States